Home

BRIDGER MANAGEMENT, LLC

CIK 1166309 · last filed 2016-11-15

BRIDGER MANAGEMENT, LLC is a corporate insider who has filed 14 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for TEVA, was dated Sep 18, 2026. Across all open-market trades the lifetime net is +$11.4M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 29 SEC filings were submitted jointly with ROBERTO MIGNONE.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

14

Lifetime Open-Market Net

$11.43M

Filer Profile

Reported Address
90 PARK AVENUE, 40TH FLOOR
NEW YORK, NY 10016
Phone
(212) 918-0820
State of Incorporation
DE
Formerly Known As
BRIDGER MANAGEMENT LLC (2002–2011)
Related Filers
ROBERTO MIGNONE — 29 joint filings, latest 2016-11-15
SWIFTCURRENT OFFSHORE, LTD. — 20 joint filings, latest 2015-11-20
BRIDGER CAPITAL LLC — 16 joint filings, latest 2012-09-17
SWIFTCURRENT PARTNERS, L.P. — 16 joint filings, latest 2012-09-17
TEVA PHARMACEUTICAL INDUSTRIES LTD — 6 joint filings, latest 2025-12-12
IRONWOOD PHARMACEUTICALS INC — 3 joint filings, latest 2012-02-14
ISTAR INC. — 3 joint filings, latest 2012-02-14
Swiftcurrent Offshore Master, Ltd. — 3 joint filings, latest 2015-11-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cardiff Oncology, Inc. (TROVW) Delisted 10%+ Owner 2,968,115 — — $11.43M 5 2016-11-15

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-18 TEVA Notice (144) −367,600 -$14.41M EDGAR
2025-12-12 TEVA Notice (144) −150,000 -$4.53M EDGAR
2025-11-26 TEVA Notice (144) −50,000 -$1.25M EDGAR
2025-11-06 TEVA Notice (144/A) −200,000 -$4.92M EDGAR
2025-09-12 TEVA Notice (144) −95,000 -$1.89M EDGAR
2024-12-20 TEVA Notice (144) −286,000 -$6.09M EDGAR
2024-06-18 TEVA Notice (144) −519,000 -$8.89M EDGAR
2016-11-15 Cardiff Oncology, Inc. (TROVW) Delisted Buy (P) −644,944 -$1.99M EDGAR
2015-11-17 — Disp (D) −5,100,000 $0
2015-07-21 Cardiff Oncology, Inc. (TROVW) Delisted Buy (P) +280,000 $2.45M EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.